Correct formation of disulfide bonds is critical for protein folding. We find that cells lacking protein disulfide isomerases can use alternative mechanisms for correct disulfide bond formation. By linking correct disulfide bond formation to antibiotic resistance, we selected mutants that catalyze correct disulfide formation in the absence of DsbC, Escherichia coli's principle disulfide isomerase. Most of our mutants massively overproduce the disulfide oxidase DsbA and change its redox status. They enhance DsbA's ability to directly form the correct disulfides by increasing the level of mixed disulfides between DsbA and substrate proteins.
Introduction
Disulfide bonds act to stabilize many protein structures (8) . The stability of disulfide-rich miniproteins, for instance, is almost entirely dependent upon disulfide bonds (9) . Although disulfide bonds are important for folding and stability, their accurate formation is difficult to achieve. This is particularly true for proteins with high levels of disulfide connectivity, because the number of possible incorrect disulfides grows factorially as the number of cysteine residues increases. In the eukaryotic endoplasmic reticulum, protein disulfide isomerase (PDI), a thioredoxin fold protein, is thought to be a key player in establishing both the initial oxidation state of protein thiols and in establishing proper connectivity (20) . PDI may be aided in these tasks by other thioredoxin-related proteins present in the endoplasmic reticulum and by the reduced glutathione (GSH)/oxidized glutathione (GSSG) redox buffer (16, 20) . Thus, in eukaryotic organisms, the pathways responsible for the initial oxidation of disulfides and their proofreading or isomerization are thought to be substantially intermingled.
In contrast, in the bacteria Escherichia coli, it has long been thought that the disulfide oxidation and disulfide error correction systems are separate entities (14, 41) . DsbA efficiently oxidizes substrates co-translocationally by forming disulfides between cysteines that are adjacent in the amino acid sequence (consecutive disulfides) (6, 25) . DsbA is then reoxidized by the membrane bound protein DsbB (4) (5) . DsbA has very little proofreading or disulfide isomerase activity (43). Proteins with nonconsecutive disulfides are thought to require the action of the E. coli disulfide isomerase, DsbC, to correct mistaken disulfide linkages formed by DsbA (14) . In order to attack incorrect disulfides, DsbC must be kept in a reduced form.
This function is performed by the membrane protein DsbD, which in turn is kept reduced by easily direct the evolution of multiple alternative mechanisms for correct disulfide formation in vivo.
Materials and Methods
Strains and Growth Conditions. Strains and plasmids used in the study are listed in Table 1 .
Unless otherwise noted, cultures were grown at 37 °C in LB medium supplemented with appropriate antibiotics. The knockout strains were generated through P1 transduction from the Keio collection stock. A dsbB1-148 truncation was generated by cam cassette insertion immediately after position G148 using the Wanner method (12) in RGP209. Then the cam cassette was removed by pCP20 plasmid to obtain strain RGP1079. RGP1126 was generated by moving the cpxR56 allele from UVC56 to RGP1079 by P1 transduction using kdgT::kan as a selection marker from the Keio collection of knockouts (3) . Thus, RGP1126 is the reconstituted strain containing the two only essential mutations from UVC56. The kan cassette was then removed by pCP20 plasmid to obtain strain RGP1146.
Plasmid Construction and Site-Directed Mutagenesis. Point mutations were introduced into the wild type bla gene in pBR322 using a Stratagene Quick Change kit (Stratagene, La Jolla, CA) and appropriate mutagenic primers, and PCR was performed as directed. The product was digested with Dpn I, precipitated using Pelletpaint® according to the protocol supplied by the manufacturer (Novagen) (Dpn I), and resuspended in ~10 µL ddH 2 O. 5 µL of product was transformed into TG1 competent cells (Stratagene). DNA was extracted from the cells and all point mutations were verified by DNA sequencing. Single disulfide bond β-lactamase mutants were made using a similar strategy but with multiple rounds of the procedure. Overexpression of DsbA was achieved by inserting the dsbA gene into pBAD33 with restriction sites XbaI, and
HindIII. The MBP-BPTI fusion protein was constructed by inserting a codon optimized BPTI after the MBP protein in the pMal-p2 (NEB) vector with the restriction sites SalI and HindIII.
Then the TEV protease recognition site of ENLYFQS was immediately inserted before the BPTI sequence.
Mutagenesis, Screening, and Mapping of Mutants Suppressing the dsbC -Ampicillin
Phenotype. RGP209 harboring pBR322 plasmid (R209 hereafter) was mutagenized with UV light. UV irradiated cells were plated to nonselection (Tet) or selection (with 1.5 g/L ampicillin)
plates and grown overnight at 37 °C . Colonies appearing on the selection plates were screened on LB plates with 50 µM cadmium to remove the loss-of-function mutants (broken disulfide bond formation machinery also suppresses the dsbC -null strain phenotype as indicated in Fig.   1C ). Colonies surviving the cadmium screen were restreaked to LB plates containing 1.5 g/L ampicillin and subsequently to Tet plates. Suppressor candidates were then collected for further tests to rule out other false-positive possibilities. Plasmids from the colonies were extracted and sequenced to guarantee no mutation in the bla gene. PCR validation of the dsbC deletion in the genome was done to confirm no environmental bacterial contamination. Linkage of the mutations to the dsbA loci was tested by P1 transduction using a yihG::Kan strain from the Keio collection. To move the dsbA loci region of UVC49, the yigZ::Kan strain from the Keio collection was used as selection for P1 transduction. The dsbA gene of each mutant was amplified with two primers 100 bp upstream or downstream of dsbA and subjected to sequence analysis. For suppressor strain UVC56, dsbB, dsbD gene were also amplified with primers 100 bp upstream and downstream, respectively, and subjected to sequence analysis. To map the other mutations in the genome, we carried out genome sequencing using a Illumina ("Solexa")
Genome Analyzer II. The genomic library was prepared according to Dr. Dave Lazinski, Tufts
University. Of the 298 sequences tested, differences were observed between ER1821 and UVC56. Five candidate genes (yhjA, dsbB, dsbG, pqiA, and cpxR) were further examined because they mapped to genes that link to envelope proteins potentially involved in protein folding. We checked these candidate genes by P1 transduction of both the wild type genes and the knockout of these genes into UVC56.
Spot Titers for Ampicillin Resistance, Cadmium Resistance, and Copper Resistance.
-lactamase or PDI -lactamase activity in vivo. Cadmium resistance was performed to quantify the relative disulfide oxidase activity of the strains in vivo. Spot titers for copper resistance were performed to quantify the relative isomerase or reductase activity in vivo as described. Briefly, strains were grown overnight in LB and diluted 1:100 into fresh LB media with appropriate antibiotics. Strains were grown to mid-logarithmic phase at 37 °C and serially diluted into 150 mM NaCl. A 2 µl aliquote of each dilution was plated onto LB plates with an ampicillin or cadmium gradient, or were plated onto Terrific Broth plates with 15-17 mM CuCl 2 . Cells were grown at 37 °C overnight. All spot titers were performed at least in triplicate.
Urokinase and BPTI Activity Assays. Urokinase assays were performed on strains transformed with plasmid pRDB8-A, which expresses mouse urokinase plasminogen activator constitutively as described in Reitsch et al(33). Periplasmic extract of bacteria grown to exponential phase were separated on nonreducing SDS-PAGE gels, and urokinase activity was demonstrated by assaying plasminogen activation by using plasminogen-casein agar. Analysis of BPTI activity was done by testing residual trypsin activity (according to the manufacturer Sigma-Aldrich instructions). A 50 µl periplasmic extract was used for a trypsin inhibition assay in a 1 ml reaction using N-α-Benzoyl-L-arginine-4-nitranilide (Roche) as the substrate. 0.5 µg This article has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof.
Results
Linking the Correct Formation of Disulfide Bonds to Bacterial Antibiotic Resistance. In order to ascertain whether there are alternative mechanisms for disulfide isomerization, we decided to select for mutants that can bypass the requirement for the E. coli principle isomerase, DsbC. TEM1 ß-lactamase is a periplasmic protein that has only a single and therefore consecutive disulfide bond (C52-C98). Although this disulfide increases the folding stability of ß-lactamase by 3.5 kJ/mol, it is not essential for ampicillin resistance (17) . To make ß-lactamase into a probe suitable for the detection of isomerase activity in vivo (a "PDI detector"), we designed an additional disulfide bond into the protein by substituting both serine 81 and threonine 108 with cysteine residues; these positions were chosen so that the connectivity of the engineered disulfide would span the native disulfide present in the protein's primary structure and, if formed correctly, would not substantially disrupt the protein tertiary structure ( Fig. 1A and B) . Serine 81 and threonine 108 were chosen because they are already very close together in the tertiary structure of ß-lactamase. We reasoned that these mutations should convert ß-lactamase into an active protein with two nonconsecutive disulfides when oxidized to its native-like conformation (Fig. 1B, iii) . Because ß-lactamase is secreted into the periplasm linearly (25), we would expect DsbA to initially oxidize the cysteines that are consecutive in the sequence (Fig. 1B, ii) , resulting in an incorrect disulfide bonding pattern that very significantly distorts the structure, and thus decrease the activity and antibiotic resistance.
Consistent with these considerations, we found that strains containing the ß-lactamase PDI detector construct are only highly resistant to ampicillin when DsbC and other components of the DsbC-DsbD disulfide isomerization pathway are present ( Fig. 1C and Fig. 2E,F) . In the absence of DsbC or DsbD, the ß-lactamase PDI detector is almost fully oxidized (Fig. 1D ) but
its oxidation pattern appears to be incorrect, as these strains are sensitive to ampicillin.
Addition of the small molecule dithiol DTT to the media restores the ampicillin resistance of strains containing the PDI detector construct (Fig. 1E) . AMS trapping experiments shown in the insert to Figure 1E indicate that the PDI detector construct is fully oxidized in the presence of DTT implying that DTT is acting as a thiol disulfide exchange reagent that facilitates isomerization rather than a direct reductant. Our results suggest that improper oxidation of ß-lactamase is inhibiting its ability to confer resistance. This was substantiated by the observation that in dsbA  strains the PDI detector ß-lactamase protein is almost fully reduced and the strains are ampicillin resistant ( evidence that the formation of nonnative disulfides in ß-lactamase interferes with its ability to encode ampicillin resistance ( Fig. 2A-D) . Our disulfide insertion design was based on the β-lactamase crystal structure that predicted that addition of the C81-C108 disulfide would not massively disrupt the β-lactamase structure. In contrast, all other disulfides, apart from the native C52-C98 bond, were expected to disrupt the structure and lead to large decreases in ampicillin resistance. The results shown in Fig. 2 confirm these predictions: the wild type protein containing the C52-C98 disulfide is the most ampicillin resistant, the variant containing the C81-C108 disulfide is somewhat resistant, and all others show lower levels of resistance.
We note that the single disulfide bond variant of C81-C108 is not as active as either fully reduced or fully oxidized wild type ß-lactamase or fully oxidized PDIdetector, as judged by
ampicillin resistance. There are a number of possible explanations for this result: 1) The engineered disulfide C81-C108 may be suboptimal in geometry, resulting in a somewhat stained configuration that in the absence of the original native disulfide bond results in less enzymatic activity than either fully reduced or fully (correctly) oxidized ß-lactamase.
2) The cysteine52-serine and cysteine98-serine substitutions may not be entirely neutral, and may decrease the activity of the reduced form of variants containing this mutation. Evidence consistent with this possibility is the previous observation, made by Huang et al (23) in their systematic study of active ß-lactamase mutants, that cysteine52 and cysteine98 could be only be substituted with only a very limited number of residues and still allow the ß-lactamase protein to retain its ability to encode ampicillin resistance. Significantly cysteine98 could only be substituted with alanine, methionine, leucine and isoleucine but not serine (23) . Control experiments showed that the ampicillin resistance of wild type ß-lactamase is almost completely unaffected by DsbA, DsbC, or DsbD mutations (Fig. 2F) , or by the presence or absence of DTT (Fig. 2B) . Taken together, these data suggest that S81C T108C ß-lactamase serves as a biomarker to monitor the disulfide isomerase activity present in a strain; henceforth, this construct is simply referred to as the PDI detector. This article has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof.
construct were subjected to five independent rounds of UV mutagenesis, and colonies resistant to 1.5 g/L ampicillin were selected as diagramed in Fig 3. Mutations in dsbA or dsbB result in sensitivity to the heavy metal cadmium (39). A large number of the mutants that we obtained were cadmium sensitive, indicating that they were either dsbA  or dsbB  ; these mutants were not analyzed further. However, 17 mutants resistant to 1.5 g/L ampicillin (4 are shown in Fig.   4A ) were cadmium resistant and motile, indicating that they retained oxidase activity. These strains were named UVC49-54 and UVC56-66.
To test if these UVC mutants were enhancing ampicillin resistance through alterations in their ability to form disulfides and not via some disulfide irrelevant mechanism, such as by changing cell permeability to the antibiotic, we examined the periplasmic expression of two other multiple disulfide bond containing proteins whose folding had previously been shown to be DsbC dependent (urokinase and bovine pancreatic trypsin inhibitor [BPTI]) (33) in three of the selected DsbC suppressors (UVC49, UVC52, and UVC56). We found that the activity of the multi-disulfide proteins in these DsbC suppressors was restored to levels at or near those seen in dsbC + strains ( Fig. 4B and Fig. 5C ). These results indicated that three different DsbC substrates are at least partially properly oxidized in these DsbC suppressor strains.
In screening these mutants for the presence of DsbA protein via Western analysis, we were struck by the fact that all the strains showed DsbA expression levels that were higher than those seen in wild type backgrounds, with most of the DsbC suppressors exhibiting very high levels of expression ( showed only ~5-fold higher DsbA levels and was termed a class II DsbC suppressor (Fig. 5A ).
Moving the wild type DsbA locus into all 16 of the class I DsbC suppressors by P1 phage co- This article has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof.
transduction resulted in restoration of the loss of ampicillin resistance ( Table 2) , showing that DsbC suppression activity for these mutants is genetically tightly linked to DsbA overexpression and is caused by a genetic alteration near the DsbA locus. In all cases the protein coding sequence of the DsbA gene was wild type. In contrast, introduction of the wild type DsbA locus into UVC56, the single class II DsbC suppressor, did not decrease its ampicillin resistance, demonstrating that the DsbC suppressor mutation in this strain is unlinked to the DsbA locus ( Table 2 ). In addition, DsbA overexpression off a plasmid in the class I DsbC suppressor UVC52 was sufficient to restore urokinase activity of a dsbC null mutant to wild type levels ( Fig. 5D ). complexes (25, 27) . We also observed an increase in the percentage of reduced DsbA present (from ~20% in wild type strains to ~50% in both the class I and II suppressors) (Fig. 4D , lower right panel). As we describe in the Discussion, the increased amounts of both reduced DsbA substrates and is resistant to copper ( Fig. 5E and Fig. 6D ), implying that UVC56 is more proficient in disulfide isomerization than are the class I suppressors. In order to determine which mutations are present in the UVC56 strain, its genome was sequenced and compared with that of the starting strain. There were 298 differences found, but mutations in just two genes, a double mutation in cpxR56 (M23I E24K) and an IS10 insertion mutation in dsbB at G135, accounted for nearly all of the suppression phenotypes. We showed this by constructing a strain (RGP1146) in which the cpxR56 and dsbB::IS10 mutations had been moved into the dsbC null strain RGP209; we found that this strain very closely resembled UVC56 in its high levels of ampicillin, cadmium, and copper resistance ( Fig. 6A and D and Fig. 7B ). DsbB is the enzyme required for reoxidation of DsbA, and CpxR is a positive regulator of the Cpx periplasmic stress response (10, 15) . The Cpx regulon is a two compontent signal transduction pathway that mediates adaptation to periplasmic protein misfolding, that consists of a sensor histidine kinase (CpxA) and a cyoplasmic response regulator (CpxR). DsbA is one of the genes under cpx control (31) . We found that reversion of the cpxR M23I E24K mutation decreased the level of DsbA present to wild type levels, showing that the increase in DsbA expression observed for UVC56 was due to this cpxR mutation and implying that this mutation is constitutively active (Fig. 6B ). Null mutants of dsbB in which the entire dsbB locus was replaced with a kanamycin resistance cassette gave the same level of suppression of ampicillin (Fig. 7C) . Examination of DsbA's oxidation status by AMS trapping experiments revealed that more reduced DsbA is present in UVC56 than in wild type strains, both in absolute amount and in the ratio of reduced to oxidized DsbA (Fig. 6B ).
The Mechanism of Class I dsbC
When the DsbB mutation was replaced by wild type DsbB, the ratio shifted slightly in the oxidized direction. Only when both the dsbB and cpxR genes were wild type was most of the DsbA present in the oxidized form. This result and the fact that DsbA was mostly reduced when only the cpxR gene was made wild type suggests that cpxR also plays a role in determining the redox status of DsbA. CpxR-mediated overproduction of DsbA may make it possible for small molecule disulfides to oxidize DsbA, resulting in a significant portion of DsbA in the oxidized form, though the main fraction remains in the reduced form. Reversion of the dsbB truncation mutation by moving a wild type dsbB locus into UVC56 resulted in a substantial decrease in ampicillin resistance of UVC56 (compare green and blue traces in Fig.   6A ). Reversion of both the cpxR and dsbB mutations caused the UVR56 strain to be almost as This article has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof.
ampicillin sensitive as the starting dsbC  strain (compare yellow and red traces in Fig. 6A ). A model that incorporates an important role of both the cpxR and dsbB mutations in the mechanism for class II DsbC suppressors is described in the Discussion.
Discussion

Mechanism of the Class I DsbC suppressors
Various pathways for the oxidation of substrate proteins by DsbA are shown in Fig 4E . This article has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof.
the concentration of mixed disulfide intermediates, as we observed (Fig. 4D upper panels) .
Increasing the percentage of substrate proteins that are in the form of mixed disulfides with DsbA increases the opportunities for proteins within this population to fold properly, bringing the correct cysteines into close juxtaposition. Dissociation of DsbA from this complex will have the effect of locking in the correct conformation. Because DsbA is a very strong oxidant, reduced DsbA will usually only be effective in reducing incorrect disulfide pairings, which are typically exposed and have relatively high redox potentials. Reduced DsbA will be much less capable of attacking structural disulfides in properly folded proteins, which are typically buried and reducing in redox potential. Thus, once the correct disulfides are formed it will be unlikely that incorrect disulfides will reform.
Another, not mutually exclusive possibility is that the higher level of DsbA leads to a higher level of substrate proteins that, at least transiently, are crosslinked to two or more DsbA molecules via mixed disulfides. The first cysteine on a substrate protein that emerges into the periplasm reacts with DsbA, resulting in the formation of a mixed disulfide (Fig. 4E, step 1 ).
When normal levels of DsbA are present, in the second step (Fig. 4E, step 2a) , the second cysteine on the substrate protein to emerge attacks this mixed disulfide. This results in the release of a reduced DsbA molecule and a substrate in which the first two cysteines are joined in a disulfide. Measurements of the rates of these two types of reactions (Fig. 4E , step 1 and step 2a) with glutathione and model peptides show that both reactions occur very rapidly (11) .
A consequence of these rapid rates is that DsbA will very rapidly react with cysteines on secreted proteins as they emerge into the periplasm (25) . The rapid rate of resolution of the mixed disulfide dictates that DsbA will remain in a mixed disulfide with the substrate protein only until an additional cysteine becomes available to resolve the mixed disulfide. Because the This article has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof.
periplasm is a very strongly oxidizing environment, free thiols are generally in short supply; the most available source of a nearby free thiol is very likely the next cysteine on the substrate protein that emerges into the periplasmic space. Thus, DsbA tends to be very effective in crosslinking adjacent thiols on proteins, but much less effective in forming nonconsecutive disulfides (6) . However, as the concentration of DsbA within the periplasm increases, it will compete more effectively with cysteines that are consecutive in the substrate protein, and instead, mixed disulfides will be formed. As the protein is synthesized, proper folding can occur and the mixed disulfides will be resolved as correct disulfides are formed in a process such as shown in step 3 of Fig. 4E . Both of these postulated mechanisms will give the substrate protein better opportunities to fold into its proper conformation, bringing the proper cysteines into proximity and allowing for correct disulfide bond formation.
Copper, a redox active metal, is thought to randomly oxidize unpaired cysteines very rapidly, so that in the presence of copper, it is important to have effective thiol/disulfide isomerases (21) . Because DsbC corrects the misoxidized disulfides it confers copper resistance to bacteria (Fig. 6D) . Curiously, the dsbC suppressor strains, with the exception of UVC56, are not any more resistant to copper than the starting dsbC  strain (Fig. 5E ). This further suggests the possibility that instead of being more proficient in disulfide isomerization as we had initially predicted, the majority of the dsbC suppressor strains may actually be better at forming the correct disulfides initially, as would be predicted by the reactions shown in Fig. 4E . This "do once, do it right" strategy would result in higher levels of urokinase, BPTI, and PDI detector expression but not necessarily increase copper resistance. We considered a model whereby CpxR-mediated overexpression of DsbA, in conjuction with a shift in the ratio of oxidized towards reduced DsbA due to the DsbB truncation, might be sufficient to allow DsbA to effectively function as both an oxidant and as an isomerase in the Class II DsbC supressors. The UVC56 strain is more resistant to copper than is wild type E.
Mechanism of Class II DsbC suppressors:
coli, and copper resistance is very closely tied to disulfide isomerization (21) . We therefore decided to closely investigate the copper resistant phenotype of UVC56. DsbA is absolutely necessary for the copper resistant suppression phenotype (Fig. 6D) . Transducing the cpxR56 point mutation into a DsbC null mutation generated a strain that is as copper resistant as UVC56, showing that cpxR56 is also very important for the copper resistant phenotype. Thus, both the dsbA and cpxR loci are strongly implicated in disulfide isomerization. Our results suggest that maintaining DsbA at the appropriate levels and redox status is important for DsbC suppression in our class II suppressors. However, it is unlikely that simply maintaining DsbA at a proper level and redox status is sufficient for isomerase activity because the class I suppressors showed similar ratios of oxidized to reduced DsbA without gaining copper resistance, and DsbA overexpression from a plasmid is not able to rescue copper resistance (Fig. 7C) . In UVC56, the DsbA expression level is not regulated by mutations close to the dsbA locus but by a mutation in cpxR, implicating CpxR regulated genes in the isomerase activity. We found through a genetic screen that dsbA and degP are both necessary for copper resistance (Fig. 6D) . A knockout of DsbA abolished copper resistance, indicating the central role of DsbA in the isomerase activity, and a knockout of DegP strongly decreased copper resistance. A Western blot also showed increased expression of DegP in the UVC56 suppressor strain (Fig. 6C) . DegP has been reported to be a protease as well as a chaperone (24, 29, 34, 38) .
Our result suggests that DegP can play a role in disulfide isomerization as well. The chaperone activity of DegP may allow it to assist DsbA in disulfide isomerization. Alternatively, the protease activity of DegP might allow it to degrade mis-oxidized substrates that accumulate to levels exceeding Dsb's isomerization capacity.
Conclusions
The error-correcting disulfide isomerase activity of DsbC allows it to rearrange the disulfides in those few secreted proteins that require nonconsecutive disulfides (Fig. 8) .
However, the relatively weak isomerase activity of DsbC may be inadequate to accurately oxidize substrates that contain complicated disulfide patterns. To explore alternate avenues of correct disulfide bond formation, we knocked out the DsbC gene and selected for suppressors that were able to efficiently form nonconsecutive disulfide bonds. The majority of the suppressors we obtained (Fig. 8B , class I) greatly overproduce DsbA and result in a shift towards more reduced DsbA. This enhances the ability of DsbA to facilitate the correct oxidation of proteins, but the copper sensitivity of these suppressors implies that they lack error-fixing ability. We did obtain a suppressor that apparently possesses error-fixing isomerase activity (Fig. 8C , class II suppressor). This suppressor (UVC56) also overproduces DsbA, although to a lesser extent, but in addition, overproduces the chaperone/protease DegP, which apparently enhances the ability of the strain to perform disulfide isomerization reactions. suggests that the redox balance in the endoplasmic reticulum is strictly regulated as well.
Elevation of the chaperone/protease DegP in our class II suppressor implies that chaperone activity also plays an important role in disulfide bond isomerization. which is consistent with the previous finding that both PDI and DsbC have chaperone activity (7, 32, 44) . DegP may be able to help fold substrate proteins by bringing non-consecutive cysteines together in space followed by DsbA functioning as an oxidase. Our ability to select for correct disulfide bond formation in vivo opens up new strategies that may contribute to selecting bacteria with an enhanced capacity to express multi-disulfide containing proteins of pharmaceutical importance. This article has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof.
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